Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Pancreas ; 36(2): e22-9, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18376296

ABSTRACT

OBJECTIVES: Bee venom (BV) has frequently been used as a remedy for inflammatory diseases. The aim of this study was to investigate the effect of BV on cholecystokinin octapeptide (CCK-8)-induced acute pancreatitis (AP) in rats. METHODS: The BV pretreatment group: 0.25 mg/kg BV was administered subcutaneously, followed by 75 mug/kg CCK-8 subcutaneously 3 times after 1, 3, and 5 hours. This whole procedure was repeated for 5 days. CONTROL GROUP: CCK-8 subcutaneously 3 times after 1, 3, and 5 hours for 5 days. The BV posttreatment group: CCK-8 subcutaneously 3 times at an interval of 2 hours for 3 days, and then 0.25 mg/kg of BV was administered subcutaneously. CONTROL GROUP: CCK-8 subcutaneously 3 times at an interval of 2 hours for 3 days. RESULTS: The BV pretreatment and posttreatment ameliorated many of the examined laboratory parameters (the pancreatic weight [PW]/body weight [BW] ratio, the serum amylase and lipase activity) and reduced histological damages in pancreas. Furthermore, BV pretreatment reduced the production of tumor necrosis factor-alpha, interleukin 1, and interleukin 6 and also decreased pancreatic nuclearfactor-kappaB binding activity compared with saline-treated group in the AP model. The BV also increased heat shock protein 60 (HSP60) and heat shock protein 72 (HSP72) compared with the saline-treated group in the AP model. CONCLUSIONS: These findings suggest that the anti-inflammatory effect of BV in CCK-8-induced AP seems to be mediated by inhibiting nuclear factor-kappaB binding activity, and that BV may have a protective effect against AP.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Bee Venoms/pharmacology , Pancreas/drug effects , Pancreatitis/prevention & control , Acute Disease , Amylases/blood , Animals , Anti-Inflammatory Agents/administration & dosage , Bee Venoms/administration & dosage , Body Weight , Chaperonin 60/metabolism , Disease Models, Animal , HSP72 Heat-Shock Proteins/metabolism , Injections, Subcutaneous , Interleukin-1/blood , Interleukin-6/blood , Lipase/blood , Male , NF-kappa B/metabolism , Organ Size , Pancreas/metabolism , Pancreas/pathology , Pancreatitis/chemically induced , Pancreatitis/metabolism , Pancreatitis/pathology , Rats , Rats, Wistar , Severity of Illness Index , Sincalide , Tumor Necrosis Factor-alpha/blood
2.
World J Gastroenterol ; 13(16): 2298-304, 2007 Apr 28.
Article in English | MEDLINE | ID: mdl-17511027

ABSTRACT

AIM: To investigate the effect of selective Cycloo-xygenase-2 (COX-2) inhibitor 4-[5-(4-Chloro-phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide (SC-236), on the cholecystokinin (CCK)-octapeptide-induced acute pancreatitis (AP) in rats. METHODS: Wistar rat weighing 240 g to 260 g were divided into three groups. (1) Normal DMSO treated group, (2) SC-236 at 4 mg/kg treated group; SC-236 systemically administered via the intravenous (i.v.) catheter, followed by 75 microg/kg CCK octapeptide subcutaneously three times, after 1, 3 and 5 h. This whole procedure was repeated for 5 d. (3) Dimethyl sulfoxide (DMSO) treated group: an identical protocol was used in this group as in the SC-236 cohort (see 2. above). Repeated CCK octapeptide treatment resulted in a typical experimentally induced pancreatitis in the Wistar rats. RESULTS: SC-236 improved the severity of CCK-octapeptide-induced AP as measured by laboratory criteria [the pancreatic weight/body weight (p.w/b.w) ratio, the level of serum amylase and lipase]. The SC-236 treated group showed minimal histologic evidence of pancreatitis and a significant reduction in myeloperoxidase activity. SC-236 also increased heat shock protein (HSP)-60 and HSP72 compared with the DMSO-treated group in the CCK-octapeptide-induced AP and also reduced the pancreatic levels of COX-2. Furthermore, SC-236 reduced proinflammatory cytokine synthesis and inhibited NF-kappaB activation compared with the DMSO-treated group in the CCK-octapeptide-induced AP. CONCLUSION: Our results suggested that COX-2 plays pivotal role in the development of AP and COX-2 inhibitors may play a beneficial role in preventing AP.


Subject(s)
Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2/metabolism , Pancreatitis/drug therapy , Pancreatitis/metabolism , Pyrazoles/pharmacology , Sulfonamides/pharmacology , Acute Disease , Animals , Chaperonin 60/genetics , Chaperonin 60/metabolism , Disease Models, Animal , Gene Expression Regulation/drug effects , HSP72 Heat-Shock Proteins/genetics , HSP72 Heat-Shock Proteins/metabolism , Interleukin-1/genetics , Interleukin-1/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Male , NF-kappa B/genetics , NF-kappa B/metabolism , Pancreas/metabolism , Pancreas/pathology , Pancreatitis/chemically induced , Rats , Rats, Wistar , Sincalide , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
3.
Exp Mol Med ; 38(4): 393-400, 2006 Aug 31.
Article in English | MEDLINE | ID: mdl-16953118

ABSTRACT

Recently, it has been reported that curcumin, which is known as a potent antioxidant, acts as a non- stressful and non-cytotoxic inducer of the cytoprotective heme oxygenase (HO)-1. In this study, naturally occurring curcuminoids, such as pure curcumin, demethoxycurcumin (DMC) and bis-demethoxycurcumin (BDMC), were compared for their potential ability to modulate HO-1 expression and cytoprotective activity in human endothelial cells. All three curcuminoids could induce HO-1 expression and HO activity with differential levels. The rank order of HO activity was curcumin, DMC and BDMC. In comparison with endothelial protection against H2O2-induced cellular injury, cytoprotective capacity was found to be highest with curcumin, followed by DMC and BDMC. Interestingly, cytoprotective effects afforded by curcuminoids were considerably associated with their abilities to enhance HO activity. Considering that the main difference among the three curcuminoids is the number of methoxy groups (none for BDMC, one for DMC, and two for curcumin), the presence of methoxy groups in the ortho position on the aromatic ring was suggested to be essential to enhance HO-1 expression and cytoprotection in human endothelial cells. Our results may be useful in designing more efficacious HO-1 inducers which could be considered as promising pharmacological agents in the development of therapeutic approaches for the prevention or treatment of endothelial diseases caused by oxidative damages.


Subject(s)
Curcumin/analogs & derivatives , Curcumin/pharmacology , Cytoprotection/drug effects , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Heme Oxygenase-1/metabolism , DNA Damage/drug effects , Diarylheptanoids , Heme Oxygenase-1/physiology , Humans , Hydrogen Peroxide/adverse effects , Models, Biological , Signal Transduction
4.
Immunopharmacol Immunotoxicol ; 28(2): 281-93, 2006.
Article in English | MEDLINE | ID: mdl-16873096

ABSTRACT

The mushroom Phellinus linteus (PL) has been shown to have antitumor and immunostimulatory effects. We hypothesized that the hot water extract of PL (WEPL) exerts its significant immunostimulatory effect by inducing production of the Th1-derived cytokine interferon-gamma (IFN-gamma) by T lymphocytes. T lymphocytes were isolated from the mice fed with 200 mg/kg of WEPL once a day for 4 weeks and then stimulated with the mitogen concanavaline A (Con A). IFN-gamma gene and intracellular protein expressions were analyzed by RT-PCR and flow cytometry, respectively. The production of IFN-gamma was measured by enzyme-linked immunosorbent assay. WEPL significantly enhanced the transcription of IFN-gamma mRNA. The effect of WEPL on IFN-gamma expression was further supported by a concomitant increase in the number of cells with intracellular IFN-gamma protein as well as the secretion of IFN-gamma. However, WEPL did not modulate either gene expression or protein secretion of interleukin-4, a Th2-associated cytokine, by Con A-stimulated T lymphocytes. Our results demonstrate that one of the potentially beneficial antitumor and immunostimulatory effects of WEPL may be mediated through the enhancement of IFN-gamma secretion by T lymphocytes.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Basidiomycota , Complex Mixtures/administration & dosage , Cytokines/biosynthesis , Gene Expression Regulation/drug effects , Th1 Cells/metabolism , Th2 Cells/metabolism , Adjuvants, Immunologic/chemistry , Administration, Oral , Animals , Basidiomycota/chemistry , Cells, Cultured , Complex Mixtures/chemistry , Cytokines/immunology , Drug Evaluation, Preclinical , Female , Gene Expression Regulation/immunology , In Vitro Techniques , Male , Mice , Th1 Cells/cytology , Th1 Cells/immunology , Th2 Cells/cytology , Th2 Cells/immunology
5.
Immunopharmacol Immunotoxicol ; 25(4): 615-25, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14686802

ABSTRACT

Cytokines produced by immune cells infiltrating pancreatic islets are important mediators of beta-cell destruction in insulin-dependent diabetes mellitus. In this study, the effects of Fructus Benincasae Recens (FBR) extract on cytokine-induced beta-cell dysfunction were examined. Fructus Benincasae Recens extract completely protected interleukin-1beta (IL-1beta) and interferon-gamma (IFN-gamma)-mediated cytotoxicity in rat insulinoma cell line (RINm5F). Incubation with FBR extract resulted in a significant reduction of IL-1beta and IFN-gamma-induced nitric oxide (NO) production, a finding that correlated well with reduced levels of the inducible form of NO synthase (iNOS) mRNA and protein. The molecular mechanism by which FBR extract inhibited iNOS gene expression appeared to involve the inhibition of NF-kappaB activation. Our results revealed the possible therapeutic value of FBR extract for the prevention of diabetes mellitus progression.


Subject(s)
Cucurbitaceae , Cytokines/pharmacology , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Nitric Oxide/biosynthesis , Animals , Cell Death/drug effects , Cell Line , Gene Expression/drug effects , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Islets of Langerhans/cytology , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Plant Extracts/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Recombinant Proteins
6.
Toxicol Lett ; 145(1): 46-54, 2003 Nov 01.
Article in English | MEDLINE | ID: mdl-12962973

ABSTRACT

Catalposide, the major iridoid glycoside isolated from the stem bark of Catalpa ovata G. Don (Bignoniaceae) has been shown to possess anti-microbial, anti-tumoral, and anti-inflammatory properties. Heme oxygenase-1 (HO-1) is a stress response protein and is known to play a protective role against the oxidative injury. In this study, we examined whether catalposide could protect Neuro 2A cells, a kind of neuronal cell lines, from oxidative damage through the induction of HO-1 protein expression and HO activity. The treatment of the cells with catalposide resulted in dose- and time-dependent up-regulations of both HO-1 protein expression and HO activity. Catalposide protected the cells from hydrogen peroxide-induced cell death. The protective effect of catalposide on hydrogen peroxide-induced cell death was abrogated by zinc protoporphyrin IX (ZnPP IX), a HO inhibitor. Additional experiments revealed the involvement of CO in the cytoprotective effect of catalposide-induced HO-1. These results indicate that catalposide is a potent inducer of HO-1 and HO-1 induction is responsible for the catalposide-mediated cytoprotection against oxidative damage.


Subject(s)
Diuretics/pharmacology , Glucosides/pharmacology , Heme Oxygenase (Decyclizing)/biosynthesis , Hydrogen Peroxide/antagonists & inhibitors , Hydrogen Peroxide/toxicity , Neurons/drug effects , Neuroprotective Agents/pharmacology , Oxidants/toxicity , Animals , Bilirubin/metabolism , Blotting, Western , Carbon Monoxide/metabolism , Cell Line , Cell Survival/drug effects , Heme Oxygenase-1 , Iron/metabolism , Membrane Proteins , Mice , Oxidative Stress/drug effects
7.
Arch Pharm Res ; 25(2): 178-83, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12009032

ABSTRACT

A high molecular weight water-soluble chitosan (WSC) with an average molecular weight of 300 kD and a deacethylation level of over 90% was produced using a simple multi-step membrane separation process. It is known that WSC prevents obesity induced by a high-fat diet. Consequently, this study investigated whether or not WSC improved the ovarian dysfunction caused by obesity in mice. The mice were fed a high density protein and lipid diet for 4 weeks, followed by the administration of WSC at 480 mg/kg body weight per day for 4 days. Thereafter, the changes in body weight, ovulation rate, in vivo and in vitro fertilization and embryonic development were measured. WSC markedly reduced the body weight of obese mice fed with a high-fat diet, but not in mice fed with a normal diet. WSC had significant effects on the ovulation rate, both the in vivo and in vitro fertilization rates and embryonic development. These results indicate an improvement in the ovarian and oviduct dysfunction caused by obesity, and suggest an adjustment in the internal secretions and metabolic functions.


Subject(s)
Chitin/analogs & derivatives , Chitin/pharmacology , Dietary Fats/administration & dosage , Fertilization in Vitro , Ovulation/drug effects , Animals , Body Weight/drug effects , Chitosan , Embryonic and Fetal Development/drug effects , Female , Mice , Microinjections , Molecular Weight , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...